全文获取类型
收费全文 | 47494篇 |
免费 | 3716篇 |
国内免费 | 1449篇 |
专业分类
耳鼻咽喉 | 98篇 |
儿科学 | 1801篇 |
妇产科学 | 348篇 |
基础医学 | 4050篇 |
口腔科学 | 225篇 |
临床医学 | 4807篇 |
内科学 | 5723篇 |
皮肤病学 | 373篇 |
神经病学 | 1266篇 |
特种医学 | 1710篇 |
外国民族医学 | 9篇 |
外科学 | 11600篇 |
综合类 | 7275篇 |
现状与发展 | 6篇 |
预防医学 | 2659篇 |
眼科学 | 349篇 |
药学 | 5368篇 |
26篇 | |
中国医学 | 2131篇 |
肿瘤学 | 2835篇 |
出版年
2024年 | 60篇 |
2023年 | 615篇 |
2022年 | 782篇 |
2021年 | 1703篇 |
2020年 | 1498篇 |
2019年 | 1364篇 |
2018年 | 1367篇 |
2017年 | 1433篇 |
2016年 | 1718篇 |
2015年 | 1817篇 |
2014年 | 2971篇 |
2013年 | 4054篇 |
2012年 | 2565篇 |
2011年 | 2801篇 |
2010年 | 2369篇 |
2009年 | 2264篇 |
2008年 | 2315篇 |
2007年 | 2361篇 |
2006年 | 2255篇 |
2005年 | 2066篇 |
2004年 | 1829篇 |
2003年 | 1534篇 |
2002年 | 1296篇 |
2001年 | 1162篇 |
2000年 | 913篇 |
1999年 | 751篇 |
1998年 | 640篇 |
1997年 | 643篇 |
1996年 | 607篇 |
1995年 | 560篇 |
1994年 | 525篇 |
1993年 | 439篇 |
1992年 | 412篇 |
1991年 | 350篇 |
1990年 | 295篇 |
1989年 | 292篇 |
1988年 | 245篇 |
1987年 | 220篇 |
1986年 | 166篇 |
1985年 | 233篇 |
1984年 | 204篇 |
1983年 | 145篇 |
1982年 | 120篇 |
1981年 | 134篇 |
1980年 | 104篇 |
1979年 | 93篇 |
1978年 | 89篇 |
1977年 | 58篇 |
1976年 | 67篇 |
1975年 | 42篇 |
排序方式: 共有10000条查询结果,搜索用时 140 毫秒
21.
AbstractBackground: Approximately, 30–40% of patients experienced hearing loss under regular hemodialysis.Objective: This study reviewed our experience on treating acute hearing loss in patients under regular hemodialysis over the past two decades.Methods: Twenty-six patients having acute hearing loss under hemodialysis were divided into two groups based on their etiologies. Sixteen patients (16 ears) with sudden sensorineural hearing loss (SSHL) were assigned to Group A and 10 patients (13 ears) with endolymphatic hydrops (EH) were assigned to Group B.Results: No significant difference was noted between Groups A and B, regardless of hemodialysis duration, clinical manifestation, underlying systemic diseases, blood examination, and vestibular test battery. In contrast, serum osmolality was significantly lower in Group B (292?±?11 mOsm/kg) than in Group A (310?±?11 mOsm/kg). Furthermore, Group B (40?±?14?dB) had better mean hearing level than Group A (87?±?21?dB) in the initial audiogram, and a higher hearing improvement rate (69%) than Group A (19%).Conclusions and significance: Both SSHL and EH are major causes for precipitating acute hearing loss in hemodialysis patients. Compared to SSHL, the less deteriorated MHL and lower serum osmolality in EH provide two clues for differentiating acute hearing loss in hemodialysis patients. 相似文献
22.
Antoine Lin Hlne Sudour‐Bonnange Virginie Languillat‐Fouquet Herv Brisse Sabine Irtan Arnauld Verschuur Sabine Sarnacki Estelle Thbaud Aurore Coulomb‐L'Hermine Anne Notz‐Carrre Jean Michon Marie‐Dominique Tabone Ccile Boulanger Isabelle Pellier Claire Freycon Georges Audry Frdrique Dijoud Magali Morelle Christophe Bergeron Claudia Pasqualini 《Pediatric blood & cancer》2020,67(6)
23.
24.
25.
Bimal Bhindi Christine M. Lohse Phillip J. Schulte Ross J. Mason John C. Cheville Stephen A. Boorjian Bradley C. Leibovich R. Houston Thompson 《European urology》2019,75(5):766-772
Background
Partial nephrectomy (PN) is generally favored for cT1 tumors over radical nephrectomy (RN) when technically feasible. However, it can be unclear whether the additional risks of PN are worth the magnitude of renal function benefit.Objective
To develop preoperative tools to predict long-term estimated glomerular filtration rate (eGFR) beyond 30 d following PN and RN, separately.Design, setting, and participants
In this retrospective cohort study, patients who underwent RN or PN for a single nonmetastatic renal tumor between 1997 and 2014 at our institution were identified. Exclusion criteria were venous tumor thrombus and preoperative eGFR <15 ml/min/1.73 m2.Intervention
RN and PN.Outcome measurements and statistical analysis
Hierarchical generalized linear mixed-effect models with backward selection of candidate preoperative features were used to predict long-term eGFR following RN and PN, separately. Predictive ability was summarized using marginal , which ranges from 0 to 1, with higher values indicating increased predictive ability.Results and limitations
The analysis included 1152 patients (13 206 eGFR observations) who underwent RN and 1920 patients (18 652 eGFR observations) who underwent PN, with mean preoperative eGFRs of 66 ml/min/1.73 m2 (standard deviation [SD] = 18) and 72 ml/min/1.73 m2 (SD = 20), respectively. The model to predict eGFR after RN included age, diabetes, preoperative eGFR, preoperative proteinuria, tumor size, time from surgery, and an interaction between time from surgery and age (marginal ). The model to predict eGFR after PN included age, presence of a solitary kidney, diabetes, hypertension, preoperative eGFR, preoperative proteinuria, surgical approach, time from surgery, and interaction terms between time from surgery and age, diabetes, preoperative eGFR, and preoperative proteinuria (marginal ). Limitations include the lack of data on renal tumor complexity and the single-center design; generalizability needs to be confirmed in external cohorts.Conclusions
We developed preoperative tools to predict renal function outcomes following RN and PN. Pending validation, these tools should be helpful for patient counseling and clinical decision-making.Patient summary
We developed models to predict kidney function outcomes after partial and radical nephrectomy based on preoperative features. This should help clinicians during patient counseling and decision-making in the management of kidney tumors. 相似文献26.
27.
Renal Denervation for Treatment of Cardiac Arrhythmias: State of the Art and Future Directions 下载免费PDF全文
JEDRZEJ KOSIUK M.D. SEBASTIAN HILBERT M.D. EVGENY POKUSHALOV M.D. GERHARD HINDRICKS M.D. Ph.D. JONATHAN S. STEINBERG M.D. ANDREAS BOLLMANN M.D. Ph.D. 《Journal of cardiovascular electrophysiology》2015,26(2):233-238
Renal Denervation for Treatment of Cardiac Arrhythmias . It has now been more than a quarter of a century since modulation of the sympathetic nervous system was proposed for the treatment of cardiac arrhythmias of different origins. But it has also been some time since some of the early surgical attempts have been abandoned. With the development of ablation techniques, however, new approaches and targets have been recently introduced that have revolutionized our way of thinking about sympathetic modulation. Renal nerve ablation technology is now being successfully used for the treatment of resistant hypertension, but the indication spectrum might broaden and new therapeutic options might arise in the near future. This review focuses on the possible impact of renal sympathetic system modulation on cardiac arrhythmias, the current evidence supporting this approach, and the ongoing trials of this method in electrophysiological laboratories. We will discuss the potential roles that sympathetic modulation may play in the future. 相似文献
28.
29.
30.
新型冠状病毒肺炎(corona virus disease 2019,COVID-19)自2019年12月爆发以来,由于具有高传染性,迅速在世界各地蔓延,国内外疫情防治形势空前严峻。COVID-19不仅造成肺部、肠道、肾脏等多脏器损害,且部分患者以眼表损害为首发或伴发症状出现,临床上很容易被忽视。COVID-19的眼表损害归属于祖国医学“天行赤眼”范畴,本文结合国内外最新的文献报道,探讨新型冠状病毒(2019 novel corona virus,2019-nCoV)对眼表的损害,阐明其可能机制,并从中西医角度提出可行的治疗措施。 相似文献